Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Unknown 1Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 68Sarcoma 4Endocrine 4Other neoplasm 3NET 3CNS 2Tumor-Agnostic 1Thoracic 1

Conditions

Rectal Neuroendocrine Tumors 2Pituitary Neoplasms 1Neuroendocrine Tumors 1

Interventions

lutetium Lu 177 dotatate 36Everolimus 32pembrolizumab 24Temozolomide 21Magnetic Resonance Spectroscopy 21Nivolumab 18lenvatinib 17gallium Ga 68 dotatate 16cabozantinib 15Cisplatin 15lanreotide 143-Iodobenzylguanidine 14Capecitabine 13trametinib 12dabrafenib 12Bevacizumab 12Octreotide 11Surveys and Questionnaires 10Surgical Procedures, Operative 10Sunitinib 10Radiosurgery 10Positron Emission Tomography Computed Tomography 10Blood Specimen Collection 10Sorafenib 9Paclitaxel 9Ipilimumab 9Carboplatin 9surufatinib 8Etoposide 8Doxorubicin 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Endoscopic Mucosal Resection × Endocrine × Clear all
NCT07612748 2026-06-03

Two Different Endoscopic Treatments for Rectal Neuroendocrine Neoplasms

Jilin University

Phase NA Recruiting
483 enrolled
EndocrineGastrointestinalNET

Rectal Neuroendocrine Tumors

NCT07373015 2026-01-28

Modified Double Snare Assisted EMR (mDS-EMR) VS ESD for Rectal Neuroendocrine Tumors Smaller Than 1cm

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase NA Not yet recruiting
118 enrolled
EndocrineGastrointestinalNET

Rectal Neuroendocrine Tumors

NCT06121752 2024-10-15

DNET

Asian Institute of Gastroenterology, India

Phase NA Unknown
54 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT03515603 2023-05-17

Endocrine Outcome of Surgery for Pituitary Adenoma

University of Ulm

Phase NA Terminated
36 enrolled
Endocrine

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡